Quest Diagnostics financials
$237.62+0.55%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B |
| Gross profit | $3.67B | $3.24B | $3.05B | $3.43B | $4.21B | $3.63B | $2.69B | $2.60B | $2.68B | $2.60B |
| Gross margin | 33.2% | 32.9% | 33.0% | 34.7% | 39.0% | 38.5% | 34.8% | 34.6% | 36.2% | 36.0% |
| Operating income | $1.54B | $1.35B | $1.30B | $1.43B | $2.38B | $1.97B | $1.23B | $1.10B | $1.17B | $1.16B |
| Net income | $988.0M | $866.0M | $850.0M | $942.0M | $1.99B | $1.43B | $835.0M | $733.0M | $769.0M | $642.0M |
| Net margin | 9.0% | 8.8% | 9.2% | 9.5% | 18.4% | 15.1% | 10.8% | 9.7% | 10.4% | 8.9% |
| Diluted EPS | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.14 | $5.28 | $5.50 | $4.51 |
| EBITDA | $2.11B | $1.84B | $1.74B | $1.86B | $2.79B | $2.33B | $1.56B | $1.41B | $1.44B | $1.41B |
| Operating cash flow | $1.89B | $1.33B | $1.27B | $1.72B | $2.23B | $2.00B | $1.24B | $1.20B | $1.18B | $1.12B |
| Free cash flow | $1.36B | $909.0M | $864.0M | $1.31B | $1.83B | $1.59B | $843.0M | $817.0M | $923.0M | $823.0M |
| Diluted shares | 113.0M | 112.6M | 113.5M | 118.0M | 128.0M | 136.0M | 136.0M | 139.0M | 140.0M | 142.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $420.0M | $549.0M | $686.0M | $315.0M | $872.0M | $1.16B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B |
| Total assets | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B |
| Total liabilities | $8.94B | $9.26B | $7.60B | $6.83B | $7.05B | $7.13B |
| Shareholders' equity | $7.21B | $6.81B | $6.34B | $5.93B | $6.48B | $6.81B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology